腫瘤植入物市場規模、佔有率和成長分析：按產品類型、材料、植入方法、最終用戶、患者群體和地區分類 - 產業預測，2026-2033 年

2024 年全球腫瘤植入物市場價值為 4.216 億美元，預計到 2033 年將成長至 8.2884 億美元，而 2025 年為 4.5448 億美元，預測期（2026-2033 年）的複合年成長率為 7.8%。

植入式腫瘤治療器械市場涵蓋了旨在取代受惡性腫瘤影響的受損骨骼部分的先進醫療設備，從而避免截肢，保住肢體並維持患者的活動能力。這一趨勢的驅動力在於肌肉骨骼癌症發生率的不斷上升以及醫療實踐中功能恢復優先的概念。支持個人化癌症治療器材的監管進步正在推動市場成長，更快的核准流程使製造商能夠將基於實證醫學的、針對特定患者的鈦植入推向市場。此類植入的應用推動了對創新數位影像處理和術前規劃軟體的需求，這些軟體對於創建客製化假體的精確3D模型至關重要。此外，人工智慧驅動的個人化技術能夠根據個體解剖結構客製化植入設計，顯著改善手術效果，並推動對植入及相關軟體解決方案的需求，從而確保市場的持續擴張。

全球腫瘤植入物市場按產品類型、材質、固定方式、最終用戶、病患小組和地區進行細分。依產品類型分類，市場分為膝關節假體、髖關節假體、肩關節假體和上肢假體。依材質分類，市場分為鈦合金、鈷鉻合金和不銹鋼。依固定方式分類，市場分為骨水泥型和非骨水泥型。依最終用戶分類，市場分為醫院、整形外科專科中心和門診手術中心。按患者群體分類，市場分為兒童和成人。依地區分類，市場分為北美、歐洲、亞太、拉丁美洲以及中東和非洲。

推動全球植入式腫瘤器械市場發展的因素

全球腫瘤植入物市場正在成長，這主要得益於醫療機構轉向採用先進的外科技術，實現精準的腫瘤切除和即時關節重組。這種方法能夠改善患者的預後和功能恢復，促使外科醫師將腫瘤植入物視為可行的選擇，而不僅僅是傳統保肢手術的替代方案。因此，符合這些先進植入的患者群體正在擴大。隨著醫療機構努力應用與不斷發展的全球整形外科腫瘤學標準一致的最新調查方法，對專用關節裝置的需求預計將會增加，從而為患者照護品質樹立新的標準。

全球植入式腫瘤治療設備市場的限制因素。

設計和製造個人化植入式腫瘤假體的高成本給全球市場帶來了巨大挑戰。這些成本限制了許多醫療機構，尤其是在預算緊張的環境下，使用這些假體。醫院往往被迫為每例手術撥付大量資金，導致其他重要服務被優先考慮，最終減少了這些植入的使用。這種經濟障礙阻礙了這些產品的推廣，尤其是在缺乏完善的報銷機制和保險支持的地區，這些地區缺乏對先進整形外科治療的保障。因此，成本效益方面的壓力正在抑制整體市場成長，影響著全球的醫療機構和病患。

全球植入式腫瘤治療器材市場趨勢

全球植入式腫瘤器械市場正呈現出對個人化製造創新發展的顯著趨勢。積層製造技術的進步提高了為每位患者客製化植入的能力，促使市場越來越重視針對個體解剖差異和腫瘤形態量身定做的解決方案。這種客製化不僅能改善術後功能、降低併發症率，還能提高臨床醫師的接受度。此外，製造商、外科醫生和監管機構之間更有效率的協作正在加速核准流程，並為整形外科腫瘤治療提供更廣泛的選擇。最終，這些進步將有助於改善患者的治療效果，並提高他們的生活品質。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球植入式腫瘤治療器械市場規模：依產品類型分類

• 膝關節人工植入物
• 髖關節內假體
• 肩關節人工植入物
• 上肢內假體

全球腫瘤植入物市場規模：依材料分類

• 鈦合金
• 鈷鉻合金
• 不銹鋼

全球可植入腫瘤裝置的市場規模：以固定方式分類

• 水泥固定型
• 無水泥

全球腫瘤植入物市場規模：依最終用戶分類

• 醫院
• 整形外科手術專科中心
• 門診手術中心

全球腫瘤植入物市場規模：依病患小組

• 兒童
• 成人

全球腫瘤植入物市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Stryker Corporation
• Zimmer Biomet Holdings, Inc.
• Johnson & Johnson
• Smith & Nephew plc
• Enovis Corporation
• Corin Group plc
• Implantcast GmbH
• Waldemar Link GmbH & Co. KG
• Arthrex, Inc.
• MicroPort Scientific Corporation
• Exactech, Inc.
• LimaCorporate SpA
• Meril Life Sciences Pvt. Ltd.
• United Orthopedic Corporation
• Baumer SA
• Onkos Surgical, Inc.
• Kyocera Corporation
• Japan MDM, Inc.
• Aesculap AG
• Orthofix Medical Inc.

結論與建議

Global Tumor Endoprostheses Market size was valued at USD 421.6 Million in 2024 and is poised to grow from USD 454.48 Million in 2025 to USD 828.84 Million by 2033, growing at a CAGR of 7.8% during the forecast period (2026-2033).

The tumor endoprostheses market consists of advanced devices designed to replace compromised bone segments affected by malignant tumors, enabling limb salvage and preserving patient mobility over amputation. This trend is driven by the increasing prevalence of musculoskeletal cancers and a shift in medical practices prioritizing functional recovery. Regulatory advancements supporting personalized oncology devices facilitate the market's growth, as expedited approval processes allow manufacturers to introduce patient-specific titanium implants based on sufficient clinical evidence. The adoption of such implants boosts demand for innovative digital imaging and pre-operative planning software, essential for creating accurate 3-D models for custom endoprostheses. Additionally, AI-driven personalization enhances implant design tailored to individual anatomy, significantly improving surgical outcomes and driving demand for both implants and supporting software solutions, thereby ensuring continued market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Tumor Endoprostheses market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Tumor Endoprostheses Market Segments Analysis

The global tumor endoprostheses market is segmented by product type, material, fixation type, end user, patient group and region. Based on product type, the market is segmented into Knee Endoprostheses, Hip Endoprostheses, Shoulder Endoprostheses and Upper Limb Endoprostheses. Based on material, the market is segmented into Titanium Alloys, Cobalt-Chromium Alloys and Stainless Steel. Based on fixation type, the market is segmented into Cemented and Cementless. Based on end user, the market is segmented into Hospitals, Orthopedic Specialty Centers and Ambulatory Surgical Centers. Based on patient group, the market is segmented into Pediatric and Adult. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Tumor Endoprostheses Market

The Global Tumor Endoprostheses market is experiencing growth driven by healthcare providers' shift towards advanced surgical techniques that facilitate precise tumor removal followed by immediate prosthetic reconstruction. This approach enhances patient outcomes and functional recovery, leading surgeons to consider tumor endoprostheses as viable options rather than merely alternatives to traditional limb-sparing methods. Consequently, the patient demographic eligible for these advanced implants is expanding. As healthcare institutions strive to adopt modern treatment methodologies that align with evolving standards in oncologic orthopedic care worldwide, the demand for specialized endoprosthetic devices is set to rise, establishing a new benchmark for quality in patient care.

Restraints in the Global Tumor Endoprostheses Market

The high costs associated with the design and production of patient-specific tumor endoprostheses pose a significant challenge in the global market. These expenses limit access for many healthcare providers, especially in budget-constrained environments. Hospitals are often forced to allocate substantial financial resources for each procedure, causing them to prioritize other essential services, ultimately leading to reduced usage of these implants. This financial barrier hampers widespread adoption, particularly in regions lacking robust reimbursement frameworks or insurance support for advanced orthopedic oncology treatments. Consequently, the pressures related to affordability impede overall market growth, affecting both healthcare providers and patients worldwide.

Market Trends of the Global Tumor Endoprostheses Market

The Global Tumor Endoprostheses market is witnessing a significant trend towards personalized manufacturing innovations. As advancements in additive manufacturing enhance the ability to create patient-specific implants, the market is increasingly favoring solutions tailored to individual anatomical variations and tumor geometries. This customization not only improves postoperative functionality and reduces complication rates but also fosters greater acceptance among clinicians. Additionally, streamlined collaboration among manufacturers, surgeons, and regulatory entities is facilitating quicker approval processes, resulting in a more diverse array of therapeutic options for oncologic orthopedic practices. Ultimately, these developments contribute to improved patient outcomes and enhanced quality of life.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Tumor Endoprostheses Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Knee Endoprostheses
• Hip Endoprostheses
• Shoulder Endoprostheses
• Upper Limb Endoprostheses

Global Tumor Endoprostheses Market Size by Material & CAGR (2026-2033)

• Market Overview
• Titanium Alloys
• Cobalt-Chromium Alloys
• Stainless Steel

Global Tumor Endoprostheses Market Size by Fixation Type & CAGR (2026-2033)

• Market Overview
• Cemented
• Cementless

Global Tumor Endoprostheses Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Orthopedic Specialty Centers
• Ambulatory Surgical Centers

Global Tumor Endoprostheses Market Size by Patient Group & CAGR (2026-2033)

• Market Overview
• Pediatric
• Adult

Global Tumor Endoprostheses Market Size & CAGR (2026-2033)

• North America (Product Type, Material, Fixation Type, End User, Patient Group)
  • US
  • Canada
• Europe (Product Type, Material, Fixation Type, End User, Patient Group)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Material, Fixation Type, End User, Patient Group)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Material, Fixation Type, End User, Patient Group)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Material, Fixation Type, End User, Patient Group)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Stryker Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet Holdings, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith & Nephew plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Enovis Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corin Group plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Implantcast GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Waldemar Link GmbH & Co. KG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arthrex, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Exactech, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LimaCorporate S.p.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meril Life Sciences Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• United Orthopedic Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baumer S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Onkos Surgical, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kyocera Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Japan MDM, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aesculap AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Orthofix Medical Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations